Free Trial

Sunshine Biopharma (SBFMW) SEC Filings & 10K Form

$0.14
+0.05 (+55.56%)
(As of 11/1/2024 ET)

Recent Sunshine Biopharma SEC Filings

DateFilerForm TypeView
10/23/2024
3:05 PM
Sunshine Biopharma Inc. (Filer)
Sunshine Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/10/2024
3:05 PM
Sunshine Biopharma, Inc (Filer)
Sunshine Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/19/2024
3:05 PM
Sunshine Biopharma, Inc (Filer)
Sunshine Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/16/2024
4:00 PM
Sunshine Biopharma, Inc (Filer)
Sunshine Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/20/2024
2:34 PM
Sunshine Biopharma, Inc (Filer)
Sunshine Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/15/2024
9:40 AM
Sunshine Biopharma, Inc (Filer)
Sunshine Biopharma (Filer)
Form NT 10-Q
05/06/2024
11:14 AM
Sunshine Biopharma, Inc (Filer)
Sunshine Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2024
3:05 PM
Sunshine Biopharma, Inc (Filer)
Sunshine Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2024
1:26 PM
Sunshine Biopharma, Inc (Filer)
Sunshine Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/28/2024
3:05 PM
Sunshine Biopharma, Inc (Filer)
Sunshine Biopharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/15/2024
10:14 AM
Sunshine Biopharma, Inc (Filer)
Sunshine Biopharma (Filer)
Form DEF 14C
03/01/2024
3:19 PM
Sunshine Biopharma, Inc (Filer)
Sunshine Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/21/2024
3:28 PM
Altium Capital Management LP (Filed by)
Sunshine Biopharma, Inc (Subject)
Sunshine Biopharma (Subject)
Form SC 13G
02/21/2024
7:24 AM
Sunshine Biopharma, Inc (Filer)
Sunshine Biopharma (Filer)
Form PRE 14C
02/15/2024
10:39 AM
Sunshine Biopharma, Inc (Filer)
Sunshine Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
10:18 AM
Sunshine Biopharma, Inc (Filer)
Sunshine Biopharma (Filer)
Form 424B4
02/12/2024
11:15 PM
Sunshine Biopharma, Inc (Filer)
Sunshine Biopharma (Filer)
Form EFFECT
02/12/2024
8:04 AM
Sunshine Biopharma, Inc (Filer)
Sunshine Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/09/2024
4:17 PM
Sunshine Biopharma, Inc (Filer)
Sunshine Biopharma (Filer)
Form S-1/A
01/30/2024
11:38 AM
Sunshine Biopharma, Inc (Filer)
Sunshine Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2024
7:10 AM
Sunshine Biopharma, Inc (Filer)
Sunshine Biopharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
12/07/2023
3:59 PM
Sunshine Biopharma, Inc (Filer)
Sunshine Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2023
8:00 AM
Sunshine Biopharma, Inc (Filer)
Sunshine Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2023
7:00 AM
Sunshine Biopharma, Inc (Filer)
Sunshine Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/02/2023
11:18 AM
Sunshine Biopharma, Inc (Filer)
Sunshine Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:SBFMW) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners